REVIEW
Published on 27 Mar 2024
A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer
doi 10.3389/fonc.2024.1373388
- 1,565 views
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Treatment Strategy for Stage III-N2 Non-Small Cell Lung Cancer: The Role of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
Treatment Strategy for Stage III-N2 Non-Small Cell Lung Cancer: The Role of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
1,084
Total downloads
4,456
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Published in
Frontiers in Oncology
- Thoracic Oncology
Impact
- 4,456Topic views
- 2,855Article views
- 1,084Article downloads